Acute coronary syndromes. The diagnostic role of troponins
1Kerckhoff Heart Center, Benekestrasse 2-8, D-61231, Bad Nauheim, Germany. christian.hamm@kerckhoff.med.uni-giessen.de
Insights
Serial troponin measurements are crucial for assessing acute coronary syndromes (ACSs). Elevated troponins indicate high risk, guiding hospitalization and treatment for myocardial infarction, while normal levels suggest a low risk of adverse events.
Area of Science:
- Cardiology
- Emergency Medicine
- Clinical Diagnostics
Background:
- Acute coronary syndromes (ACSs) are critical, life-threatening manifestations of coronary heart disease.
- Standard diagnostic methods like EKG and CK-MB may be insufficient for evaluating patients, especially those without persistent ST elevations.
- Accurate risk stratification is essential for effective patient management in ACS.
Purpose of the Study:
- To evaluate the diagnostic and prognostic utility of serial troponin T or troponin I measurements in patients presenting with symptoms suggestive of acute coronary syndromes.
- To determine the effectiveness of troponin testing in risk stratifying patients with unstable angina and guiding treatment decisions.
- To assess the impact of troponin levels on short-term (30-day) risk of death or myocardial infarction.
Main Methods:
- Serial measurements of troponin T or troponin I were performed after hospital admission in patients presenting with potential ACS.
- Patients were categorized based on troponin levels (elevated vs. non-elevated).
- Clinical outcomes, including death and myocardial infarction, were assessed at 30-day follow-up.
Main Results:
- Non-elevated troponin levels in patients with unstable angina were associated with a low 30-day risk (≤1%) of death or myocardial infarction.
- Elevated troponin levels identified a high-risk group (approximately 20% 30-day risk of myocardial infarction and death) requiring hospitalization and further evaluation.
- Troponin testing provides superior risk stratification compared to traditional methods in this patient population.
Conclusions:
- Serial troponin testing is a highly effective tool for risk stratification in patients with acute coronary syndromes, particularly those presenting as unstable angina.
- Patients with elevated troponins represent a high-risk group necessitating aggressive management and early revascularization, potentially with glycoprotein IIb/IIIa antagonists.
- The absence of troponin elevation indicates a favorable prognosis, potentially allowing for less intensive management and contributing to cost-effectiveness in healthcare.
Abstract:
Acute coronary syndromes (ACSs) represent the acute life-threatening phases of coronary heart disease. Clinical symptoms, EKG, and CK-MB measurements are frequently insufficient to evaluate patients without persisting ST elevations. Serial determinations of troponin T or troponin I after arrival in hospital disclose minor myocardial injury in patients presenting as unstable angina. This finding allows the currently best risk stratification and may contribute to cost-effectiveness. Without elevated troponins the risk for death or myocardial infarction during 30 days follow-up is not more than 1%. The lack of elevated troponins does not implicate that these patients do not have coronary artery disease. Patients with positive evidence of troponins represent a high-risk group who should be hospitalized and further evaluated, because the risk for myocardial infarction and death in 30 days is approximately 20%. Current studies indicate that early revascularization under glycoprotein IIb/IIIa antagonists represent the optimal treatment.
Related Concept Videos
Acute Coronary Syndrome III: Diagnostic Studies
Acute Coronary Syndrome I: Introduction
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Angina III: Clinical Manifestations and Assessment
Acute Coronary Syndrome V: Nursing Management
